1613619-44-5Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
Paragraph 0519; 0520; 0521; 0522, (2014/06/25)
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HNE is implicated.
NOVEL COMPOUNDS
-
Page/Page column 77, (2014/07/08)
This invention relates to heterocyclic compounds, which are pyrimidinone derivatives having human neutrophil elastase inhibitory properties, and their use in therapy.
